Regulation of gene expression of hepatic drug metabolizing enzymes and transporters by the Toll-like receptor 2 ligand, lipoteichoic acid
- 1 January 2009
- journal article
- Published by Elsevier BV in Archives of Biochemistry and Biophysics
- Vol. 481 (1), 123-130
- https://doi.org/10.1016/j.abb.2008.10.003
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Rosiglitazone attenuates suppression of RXRα-dependent gene expression in inflamed liverJournal of Hepatology, 2007
- Mutual repression between steroid and xenobiotic receptor and NF- B signaling pathways links xenobiotic metabolism and inflammationJCI Insight, 2006
- Is nuclear factor kappa-B the missing link between inflammation, cancer and alteration in hepatic drug metabolism in patients with cancer?European Journal Of Cancer, 2006
- Phosphorylation of cytochromes P450: First discovery of a posttranslational modification of a drug-metabolizing enzymeBiochemical and Biophysical Research Communications, 2005
- Toll-like receptor signallingNature Reviews Immunology, 2004
- NUCLEAR RECEPTOR, PREGNANE X RECEPTOR, IS REQUIRED FOR INDUCTION OF UDP-GLUCURONOSYLTRANSFERASES IN MOUSE LIVER BY PREGNENOLONE-16α-CARBONITRILEDrug Metabolism and Disposition, 2003
- Lipopolysaccharide and Cecal Ligation/Puncture Differentially Affect the Subcellular Distribution of the Pregnane X Receptor but Consistently Cause Suppression of Its Target Genes CYP3AShock, 2003
- Pathophysiological Factors Affecting CAR Gene ExpressionDrug Metabolism Reviews, 2003
- Induction of NO Synthesis by Lipoteichoic Acid fromStaphylococcus aureusin J774 Macrophages: Involvement of a CD14-Dependent PathwayBiochemical and Biophysical Research Communications, 1997
- The RXR heterodimers and orphan receptorsCell, 1995